image
unknown | table
stringlengths 34
20.2k
| sample_id
int64 0
153k
|
---|---|---|
null | |Characteristic | Current Asthma | No Asthma |
|---|---|---|
| Chest|
|Tightness | 0.33 | 0.08 |
| Cough | 0.48 | 0.18 |
| Shortness of|
|Breath | 0.29 | 0.07 |
| Wheezing | 0.22 | 0.02| | 100 |
null | |Characteristic | 16-35 years | 36-55 years | <55 years |
|---|---|---|---|
| Female | 31.0 | 32.3 | 27.3 |
| Male | 24.8 | 18.1 | 51.1 |
| All | 28.4 | 25.2 | 39.6| | 101 |
null | |Characteristic | V/V | V/M+M/M |
|---|---|---|
| Preadolescence | 2040.27 | 2279.0| | 102 |
null | |Characteristic | 2005 | 2006 |
|---|---|---|
| Feb | 0.22 | 0.01 |
| Apr | 0.0 | 0.54 |
| Jun | 0.01 | 0.05 |
| Aug | 0.46 | 0.03 |
| Oct | 0.51 | 0.04 |
| Dec | 0.11 | 0.03| | 103 |
null | |Characteristic | SO3 | CaO | Al2O3 | SiO2 |
|---|---|---|---|---|
| ESA 700\degree C | 25.87 | 33.08 | 7.79 | 13.23 |
| ESA 800\degree C | 27.2 | 35.06 | 8.41 | 14.0 |
| ESA 900\degree C | 28.63 | 38.78 | 8.07 | 13.65 |
| ESA 1000\degree C | 24.17 | 39.82 | 9.86 | 16.86 |
| ESA 1100\degree C | 19.48 | 44.42 | 9.3 | 16.98| | 104 |
null | |Characteristic | Carbide | Al2O3/TiAIN | Diamond |
|---|---|---|---|
| Dry | 0.76 | 0.77 | 0.69 |
| MQL | 0.56 | 0.55 | 0.47| | 105 |
null | |Characteristic | Ti:Al=3.92:1 | Ti:Al=1.33:1 | Ti:Al=0.65:1 |
|---|---|---|---|
| 100.0 | 122.45 | 207.0 | 478.14 |
| 300.0 | 626.83 | 740.54 | 871.73 |
| 500.0 | 1788.86 | 2319.67 | 2739.56| | 106 |
null | |Characteristic | Value |
|---|---|
| BSA solution-310 | 3.06 |
| BSA solution-298 | 8.77 |
| serum-310K | 20.84 |
| serum-298K | 21.45 |
| plasma-310K | 23.64 |
| plasma-298K | 26.95| | 107 |
null | |Characteristic | HTM | spiro-OMeTAD ref. |
|---|---|---|
| FDT | 20.2 | 19.74 |
| EDOT-AZO | 10.94 | 11.9 |
| PTAA | 22.18 | 0.11 |
| NiO | 15.85 | 0.11 |
| Spiro-FL-III | 20.75 | 18.77| | 108 |
null | |Characteristic | Value |
|---|---|
| Relationship formulation | 41.7 |
| Emotional |
| sexual connection | 36.0 |
| Volume |
| variety | 30.9 |
| Sexual actions |
| behaviours | 15.9 |
| Free from physical harm | 11.7 |
| Overcoming psychological |
| social barriers | 9.1 |
| Idealised physical attributes | 5.2 |
| Settings or physical spaces | 1.5 |
| Participant unsure | 2.7| | 109 |
null | |Characteristic | Value |
|---|---|
| NE | 2.97 |
| GE1 | 0.7 |
| GE3 | 0.52 |
| GE5 | 0.68 |
| GE7 | 2.47 |
| FE | 1.94 |
| GFE | 1.35| | 110 |
null | |Characteristic | Value |
|---|---|
| PMMA-35-BDP | 95.84 |
| PMMA-25-BDP | 95.07 |
| PMMA-20-BDP | 94.68 |
| PMMA-10-BDP | 93.14 |
| PMMA-20-ExOP 1230 | 83.13 |
| PMMA-15-ExOP1230 | 83.9 |
| PMMA-10-ExOP 1230 | 81.59 |
| PMMA-5-ExOP 1230 | 82.36 |
| PMMA-20-ExOP935 | 79.66 |
| PMMA-15-ExOP935 | 83.13 |
| PMMA-10-ExOP935 | 84.28 |
| PMMA-5-ExOP935 | 88.14 |
| PMMA | 0.15| | 111 |
null | |Characteristic | No comorbidity | >= 1 comorbidity |
|---|---|---|
| Not pregnant | 0.31 | 0.33 |
| First trimester | 0.39 | 0.81 |
| Second trimester | 0.44 | 0.57 |
| Third trimester | 0.44 | 0.56| | 112 |
null | |Characteristic | Decreasing BMI sds trajectory (n=416) | Increasing BMI sds trajectory (n=197) |
|---|---|---|
| Screentime> 2 hours per day - 2006 | 0.06 | 0.06 |
| Screentime > 2 hours per day - 2012 | 0.57 | 0.65 |
| Tv viewing > 2 hours per day - 2006 | 0.03 | 0.04 |
| Tv viewing > 2 hour per day - 2012 | 0.09 | 0.14 |
| Organised sports < 1 hour per week - 2006 | 0.66 | 0.69 |
| Organised play < 1 hour per week - 2012 | 0.14 | 0.2 |
| Outside play < 1 hour per day - 2006 | 0.59 | 0.55 |
| Outside play < 1 hour per day - 2012 | 0.52 | 0.48 |
| Sugared drinks > 3 glasses per day - 2006 | 0.46 | 0.54 |
| Sugared drinks > 3 glasses per day - 2012 | 0.34 | 0.4 |
| Fruit < 2 portions a day - 2006 | 0.73 | 0.72 |
| Fruit < 2 portions a day - 2012 | 0.82 | 0.76 |
| Vegetable intake < 5 days a week - 2006 | 0.55 | 0.61 |
| Vegetable intake < 5 days a week - 2012 | 0.6 | 0.53| | 113 |
null | |Characteristic | Value |
|---|---|
| EP-35-BDP | 33.64 |
| EP-25-BDP | 39.04 |
| EP-20-BDP | 30.56 |
| EP-10-BDP | 68.36 |
| EP-20-ExRP | 94.14 |
| EP-15-ExRP | 93.75 |
| EP-10-ExRP | 92.21 |
| EP-5-ExRP | 91.44 |
| EP-20-ExOP 1230 | 70.22 |
| EP-15-ExOP1230 | 69.83 |
| EP-10-Ex0P1230 | 70.22 |
| EP-5-ExOP1230 | 67.52 |
| EP-20-ExOP935 | 68.06 |
| EP-15-ExOP935 | 69.14 |
| EP-10-ExOP935 | 68.67 |
| EP-5-ExOP935 | 69.06 |
| EP | 0.0| | 114 |
null | |Characteristic | Indigenous females | Non-tndigenous females |
|---|---|---|
| 18-24 | 13.86 | 5.98 |
| 25-34 | 18.11 | 5.8 |
| 35-44 | 20.76 | 6.51 |
| 45-54 | 19.7 | 7.66 |
| 55-64 | 14.3 | 6.07| | 115 |
null | |Characteristic | DD | MIC |
|---|---|---|
| IMP | 93.78 | 93.78 |
| MER | 89.22 | 89.5 |
| CAZ | 96.91 | 98.62 |
| CPM | 95.2 | 96.63 |
| CIP | 90.93 | 90.64 |
| LEV | 87.51 | 89.79 |
| AZT | 92.35 | 87.22 |
| PPT | 92.35 | 96.63 |
| AMI | 72.11 | 78.1 |
| GEN | 76.67 | 84.09 |
| POL | 16.82 | 39.33| | 116 |
null | |Characteristic | Value |
|---|---|
| Administers remedies concomitantly with|
|ARVs | 46.0 |
| Administers remedies with ARVs but at|
|different times | 43.0 |
| Entirely replaces ARVs with non-prescription|
|remedies | 3.0 |
| Uses non-prescription remedies | 33.0| | 117 |
null | |Characteristic | Alcohol | Tobacco |
|---|---|---|
| Mouth | 38.0 | 14.0 |
| Lungs | 97.0 | 20.0 |
| Ears | 4.0 | 3.0 |
| Brain | 37.0 | 49.0 |
| Liver | 34.0 | 62.0 |
| Esophagus | 15.0 | 26.0 |
| Kidneys | 33.0 | 48.0 |
| Bladder | 8.0 | 32.0 |
| Heart | 78.0 | 54.0 |
| Blood circulation | 55.0 | 54.0 |
| Fetus | 74.0 | 59.0| | 118 |
null | |Characteristic | 65+ | 45~64 | 19~44 | 7~18 | <6 |
|---|---|---|---|---|---|
| suffocation | 3.89 | 2.63 | 1.18 | 0.76 | -4.61 |
| drowning | -0.41 | 1.18 | -0.34 | -2.09 | -0.08 |
| fire | -1.44 | 0.17 | 0.24 | 1.95 | 2.24 |
| fall | 23.76 | 9.03 | 5.15 | 1.76 | 3.4 |
| poisoning | -4.09 | -3.51 | -2.02 | -2.8 | -0.41 |
| transport | -22.18 | -9.78 | -4.48 | -0.08 | -6.93| | 119 |
null | |Characteristic | intervention Group | no intervention Group |
|---|---|---|
| 6weeks | 97.39 | 82.39 |
| 10weeks | 95.99 | 79.61 |
| 14weeks | 94.6 | 74.38| | 120 |
null | |Characteristic | Carbide | Al2O3/TiAIN | Diamond |
|---|---|---|---|
| Dry | 446.18 | 432.73 | 460.67 |
| MQL | 318.88 | 383.74 | 358.21| | 121 |
null | |Characteristic | GCKR Expression | GCK Expression |
|---|---|---|
| Liver | 4.73 | 0.76 |
| Islets 1 | 0.22 | 1.83 |
| Islets 2 | 0.3 | 2.34 |
| Pancreas | 0.12 | 0.53 |
| Adipocytes | 0.12 | 0.1 |
| Skeletal|
|Muscle | 0.09 | 0.01 |
| Kidney | 0.01 | 0.02| | 122 |
null | |Characteristic | Value |
|---|---|
| Provision of cool drinking water | 522.52 |
| Broad brimmed hats supplied | 292.05 |
| Rescheduling work time | 253.31 |
| Central cooling system or air conditioning | 255.3 |
| Electric fan | 253.31 |
| Shady rest area | 249.34 |
| Stopping work if the temprature exceeds 40 degree C | 147.02 |
| Others | 72.52| | 123 |
null | |Characteristic | Women | Men |
|---|---|---|
| 0-9 | 8.22 | 16.45 |
| 10-19 | 36.64 | 36.64 |
| 20-29 | 371.59 | 211.59 |
| 30-39 | 150.28 | 115.89 |
| 40-49 | 88.97 | 45.61 |
| 50-59 | 63.55 | 35.89 |
| 60-69 | 17.94 | 6.73 |
| 70-79 | 20.19 | 6.73 |
| 80+ | 5.23 | 0.75| | 124 |
null | |Characteristic | 1 | 0 | 12 |
|---|---|---|---|
| P | 15.49 | 11.63 | 9.08 |
| 1.0 | 8.9 | 3.8 | 1.34 |
| 2.0 | 8.65 | 4.5 | 1.18 |
| 3.0 | 8.24 | 4.68 | 1.32 |
| 4.0 | 8.5 | 4.39 | 1.52 |
| 5.0 | 8.59 | 4.59 | 1.27 |
| 6.0 | 8.75 | 4.78 | 1.15 |
| 7.0 | 8.76 | 5.21 | 1.26 |
| 8.0 | 8.04 | 5.34 | 1.15 |
| 9.0 | 7.73 | 4.97 | 1.09 |
| 10.0 | 8.07 | 5.16 | 1.0 |
| 11.0 | 8.32 | 5.44 | 0.99| | 125 |
null | |Characteristic | Value |
|---|---|
| Tested recently | 5.79 |
| Don't want to know status | 16.14 |
| Not at risk | 26.44 |
| No symptoms | 27.29 |
| Do not want to be tested in context of this study | 31.29 |
| No time/too far away | 44.07| | 126 |
null | |Characteristic | Value |
|---|---|
| 0.0 | 71.57 |
| 1.0 | 32.4 |
| 2.0 | 31.97 |
| 3.0 | 12.81 |
| 4.0 | 12.39 |
| 5.0 | 6.49| | 127 |
null | |Characteristic | Value |
|---|---|
| 1.03 | 3.64 |
| 2.03 | 2.0 |
| 2.94 | 1.82 |
| 3.94 | 1.5 |
| 4.89 | 1.39 |
| 5.93 | 1.35 |
| 6.98 | 1.17 |
| 7.98 | 1.13 |
| 8.97 | 1.11 |
| 9.97 | 1.06 |
| 11.02 | 0.94 |
| 11.97 | 0.93 |
| 13.97 | 0.83 |
| 15.96 | 0.79 |
| 17.01 | 0.71 |
| 17.96 | 0.7 |
| 20.91 | 0.57 |
| 23.9 | 0.44 |
| 24.95 | 0.43 |
| 27.03 | 0.31| | 128 |
null | |Characteristic | Value |
|---|---|
| Control | 29.93 |
| T5 | 34.98 |
| T10 | 49.8 |
| T15 | 54.85 |
| T5Z10 | 39.86 |
| T5Z15 | 39.86 |
| T10Z10 | 44.91 |
| T10Z15 | 49.8 |
| T15Z10 | 49.8 |
| T15Z15 | 54.85| | 129 |
null | |Characteristic | No FS | FS |
|---|---|---|
| 1:10 | 62.45 | 63.67 |
| 1:50 | 65.28 | 79.81 |
| 1:100 | 68.11 | 85.06 |
| 1:150 | 68.11 | 85.06 |
| 1:200 | 68.11 | 82.64| | 130 |
null | |Characteristic | Value |
|---|---|
| Forgetfullness | 0.28 |
| Child's refusal to take the drugs | 0.19 |
| Transportation problem | 0.19 |
| Run out of pills | 0.13 |
| Illness of the caregivers | 0.06 |
| Pill burden | 0.04 |
| Side effects of drugs | 0.04 |
| Illness of the child | 0.03 |
| Taste of the drugs | 0.02 |
| Others | 0.01| | 131 |
null | |Characteristic | Winter | Spring | Summer | Fall |
|---|---|---|---|---|
| 0-1y | 105.28 | 89.08 | 99.39 | 104.54 |
| 2-5y | 69.94 | 64.79 | 69.94 | 73.62 |
| 6-11y | 48.59 | 51.53 | 57.42 | 59.63 |
| 12-16y | 39.75 | 47.85 | 55.95 | 58.16| | 132 |
null | |Characteristic | Value |
|---|---|
| Group 1 | 0.03 |
| Group II | 0.01 |
| Group III | 0.01 |
| Group IV | 0.02 |
| Group V | 0.02 |
| Group VI | 0.02| | 133 |
null | |Characteristic | Value |
|---|---|
| Don't have time to get tested | 0.06 |
| Don't know where to get tested | 0.07 |
| Afraid of positive results | 0.07 |
| Afraid of testing | 0.12 |
| Ashamed of testing | 0.22 |
| Presume to be HIV negative | 0.25| | 134 |
null | |Characteristic | DIF<10 | DIF>=10 |
|---|---|---|
| <=50 | 1.71 | -0.02 |
| 50-55 | 2.42 | 2.05 |
| 55-60 | 3.18 | 2.32 |
| 60-65 | 2.37 | 2.9 |
| >65 | 4.51 | 3.55| | 135 |
null | |Characteristic | Overweight | Obesity |
|---|---|---|
| Stockholm area | 1.0 | 1.01 |
| Gothenburg area | 1.09 | 1.13 |
| Malmo area | 1.15 | 1.27 |
| Larger municipalities | 1.26 | 1.52 |
| Central district municipalities | 1.34 | 1.69 |
| Densely populated municipalities | 1.33 | 1.72 |
| Sparsely populated municipalities | 1.43 | 1.89| | 136 |
null | |Characteristic | Control | PVA | PB1 | PB5 | PB10 | PB20 |
|---|---|---|---|---|---|---|
| 24.0 | 100.05 | 89.66 | 98.06 | 96.3 | 95.06 | 92.63 |
| 72.0 | 100.05 | 54.3 | 73.22 | 61.37 | 61.64 | 60.0| | 137 |
null | |Characteristic | Value |
|---|---|
| 10.0 | 100.0 |
| 11.0 | 100.0 |
| 12.0 | 98.0 |
| 13.0 | 95.0 |
| 14.0 | 96.0 |
| 15.0 | 85.0 |
| 16.0 | 84.0 |
| 17.0 | 80.0 |
| 18.0 | 70.0 |
| 19.0 | 71.0| | 138 |
null | |Characteristic | Value |
|---|---|
| 150.0 | 0.97 |
| 200.0 | 0.99 |
| 250.0 | 0.99 |
| 300.0 | 0.58 |
| 1500.0 | 0.33 |
| Wind | 0.38| | 139 |
null | |Characteristic | Scenario A | Scenario B | Scenario C | Scenario D |
|---|---|---|---|---|
| Total | 296.84 | 86.32 | 1248.42 | 2014.74 |
| Under 75 | 271.58 | 170.53 | 583.16 | 810.53 |
| Cardiovascular disease | 212.63 | 195.79 | 920.0 | 1627.37 |
| Diabete | 2.11 | -73.68 | 10.53 | 10.53 |
| Cancer | 18.95 | 27.37 | 178.95 | 338.95 |
| Liver disease | 61.05 | -65.26 | 94.74 | 35.79 |
| Diet (not including alcohol) | 204.21 | 27.37 | 1147.37 | 1964.21 |
| Fruit and vegetables | -511.58 | 515.79 | -132.63 | 953.68 |
| Fibre | 229.47 | 456.84 | 246.32 | 465.26 |
| Fate | 524.21 | 751.58 | 465.26 | 600.0 |
| salt | -73.68 | -166.32 | -98.95 | -157.89 |
| Alcohol consumption | 94.74 | 52.63 | 94.74 | 52.63| | 140 |
null | |Characteristic | TBLN POSITIVE | TBLN NEGATIVE |
|---|---|---|
| CERVICAL | 1133.4 | 423.04 |
| AXILLARY | 461.1 | 270.82 |
| INGUINAL | 150.32 | 61.52 |
| SUPRACLAVICULAR | 207.4 | 42.49 |
| SUBMANDIBULAR | 308.88 | 182.03 |
| AURICULAR | 10.78 | 10.78 |
| NECK | 102.75 | 45.67 |
| OTHERS | 10.78 | 20.3| | 141 |
null | |Characteristic | Co-stigma | Shared Stigma | HIV/AIDS Stigma |
|---|---|---|---|
| Model 1 (Additive) | 20.15 | -0.01 | 19.83 |
| Model 2 (Completely|
|Overlapping) | 0.19 | 19.98 | 0.0 |
| Model 3 (Partially|
|Overlapping) | 10.35 | 9.96 | 9.87| | 142 |
null | |Characteristic | Value |
|---|---|
| Cardiovascular sys | 0.26 |
| Nervous sys | 0.1 |
| Muskulo-skeletal sys | 0.08 |
| Alimentary tract | 0.07 |
| syst Hormonal preperations | 0.07 |
| Respiratory tract | 0.06| | 143 |
null | |Characteristic | MRC (Mild) | MRC (Moderate) | MRC (Severe) |
|---|---|---|---|
| USA | 11.79 | 63.16 | 23.04 |
| UK | 22.02 | 50.13 | 27.9 |
| Turkey | 30.2 | 36.84 | 33.01 |
| Germany | 46.04 | 44.0 | 6.94 |
| China | 85.14 | 13.84 | -0.13 |
| Brazil | 16.91 | 41.95 | 36.84| | 144 |
null | |Characteristic | T1 | T2 |
|---|---|---|
| Sound from aircraft | 49.1 | -0.04 |
| Careless bicycle riding | 17.17 | 12.98 |
| Crowding | 16.15 | 10.38 |
| Road traffic noise | 10.38 | 4.26 |
| Dogs | 9.13 | 9.58 |
| Vehicles on forest roads | 8.79 | 5.17 |
| Human enroachment on the.. | 6.98 | 5.39 |
| Seeing aircraft | 3.35 | 0.18| | 145 |
null | |Characteristic | ProCAD | IPS e.max CAD | IPS e.maxZirCAD |
|---|---|---|---|
| 0.0 | 83.48 | 88.99 | 81.78 |
| 30.0 | 84.65 | 88.95 | 79.73 |
| 90.0 | 87.64 | 91.56 | 83.1| | 146 |
null | |Characteristic | Value |
|---|---|
| 10.0 | 0.51 |
| 20.04 | 0.44 |
| 28.07 | 0.38 |
| 29.92 | 0.37 |
| 33.51 | 0.36 |
| 39.97 | 0.36 |
| 49.95 | 0.34 |
| 59.89 | 0.34| | 147 |
null | |Characteristic | Value |
|---|---|
| 200~400 | 18111.55 |
| 400~600 | 26768.19 |
| 600~800 | 11647.92 |
| 800~1000 | 6569.36 |
| 1000~1200 | 4260.92 |
| 1200~1400 | 3222.12 |
| 1400~1600 | 2529.59 |
| 1600~1800 | 1952.48 |
| 1800~2000 | 1606.22 |
| >2k | 11186.23| | 148 |
null | |Characteristic | Value |
|---|---|
| c -625 A>C | 0.59 |
| c.-458 G>A | 0.64 |
| c.-261 G>A | 0.46 |
| c.-233 C>T | 0.87 |
| c.-232 G>A | 0.87 |
| WT | 1.0 |
| Basic | 0.1| | 149 |
null | |Characteristic | [unnamed data series #0] | [unnamed data series #1] |
|---|---|---|
| All | 21.21 | 50.69 |
| 99% | 21.29 | 36.12 |
| 90% | 22.14 | 18.31 |
| 80% | 25.32 | 12.55 |
| 50% | 28.3 | 3.79 |
| 33% | 30.99 | 0.02| | 150 |
null | |Characteristic | Round 1 | Round 2 |
|---|---|---|
| Karongi | 1.37 | 1.09 |
| Ngororero | 1.47 | 1.5 |
| Nyabihu | 1.31 | 1.28 |
| Nyamasheke | 1.27 | 1.75 |
| Rubavu | 1.65 | 1.21 |
| Rusizi | 1.6 | 2.0 |
| Rutsiro | 1.31 | 1.21| | 151 |
null | |Characteristic | Value |
|---|---|
| OPD | 0.19 |
| Chronic IIIness Follow UP Clinic | 0.06 |
| Ophthamology | 0.04 |
| Obsteterics |
| Gynecology | 0.07 |
| Pediatrics | 0.14 |
| Psychiatry | 0.03 |
| Major operation room | 0.07 |
| Intensive Care Unit | 0.03 |
| Surgical ward | 0.2 |
| Medical ward | 0.17| | 152 |
null | |Characteristic | up-regulated | down-regulated |
|---|---|---|
| 2-5 | 147.64 | 135.28 |
| 5-10 | 101.06 | 33.56 |
| 10-15 | 25.0 | 9.79 |
| 15-20 | 6.94 | 5.99 |
| 20-50 | 11.69 | 2.19 |
| >50 | 4.09 | 4.09| | 153 |
null | |Characteristic | Atlanta | Denver | Houston |
|---|---|---|---|
| NOx | 0.68 | 0.58 | 0.75 |
| CO | 0.72 | 0.76 | 0.63 |
| EC | 0.67 | 0.83 | 0.64 |
| IMISIGV | 0.76 | 0.74 | 0.73 |
| IMSIDV | 0.75 | 0.82 | 0.73 |
| IMISEB | 0.8 | 0.83 | 0.77 |
| PMFGV | 0.31 | 0.28 | 0.31 |
| PMFDV | 0.59 | 0.83 | 0.56 |
| PMFMB | 0.63 | 0.77 | 0.45| | 154 |
null | |Characteristic | 1 wt% | 2 wt % | 3 wt% | 4 wt% | 5 wt% |
|---|---|---|---|---|---|
| 15.0 | 67.87 | 65.9 | 64.28 | 65.13 | 63.16 |
| 20.0 | 65.9 | 65.06 | 65.13 | 64.84 | 63.16 |
| 25.0 | 64.92 | 63.09 | 63.44 | 62.31 | 61.75 |
| 30.0 | 65.2 | 63.93 | 64.0 | 63.72 | 63.16 |
| 35.0 | 64.07 | 63.23 | 62.31 | 60.27 | 59.01| | 155 |
null | |Characteristic | Value |
|---|---|
| Orthopedics | 79.0 |
| Occupational health service | 78.0 |
| Pain management | 74.0 |
| Oncology | 71.0 |
| Rehabilition | 63.0 |
| Psychiatry | 60.0 |
| Rheumatology | 49.0 |
| Neurology | 45.0 |
| Other | 43.0 |
| Primary health care | 43.0 |
| Surgery | 38.0 |
| Gynecology | 32.0 |
| Ear, Nose and Throat | 22.0 |
| Internal medicine | 21.0 |
| Infectious diseases | 20.0 |
| Administration | 9.0 |
| Child and adolescent care | 7.0 |
| Ophthalmology | 4.0 |
| Geriatrics | 4.0 |
| Dermatology | 3.0| | 156 |
null | |Characteristic | PM10 | PM2.5 | SO2 | O3 | NO2 |
|---|---|---|---|---|---|
| SUNDAY | 0.96 | 0.98 | 0.98 | 1.03 | 0.95 |
| MONDAY | 1.0 | 0.97 | 1.02 | 0.96 | 1.05 |
| TUESDAY | 1.03 | 1.02 | 1.02 | 0.94 | 1.06 |
| WEDNESDAY | 1.02 | 1.02 | 1.01 | 0.94 | 1.06 |
| THURSDAY | 1.03 | 1.05 | 1.02 | 0.94 | 1.07 |
| FRIDAY | 1.03 | 1.01 | 1.03 | 0.94 | 1.08 |
| SATURDAY | 1.0 | 1.0 | 1.0 | 1.0 | 1.0| | 157 |
null | |Characteristic | Value |
|---|---|
| 0.15 | 0.03 |
| 0.97 | 0.21 |
| 2.02 | 0.31 |
| 3.0 | 0.39 |
| 4.04 | 0.44 |
| 5.02 | 0.47 |
| 5.99 | 0.51 |
| 8.01 | 0.56 |
| 10.04 | 0.59 |
| 12.25 | 0.62 |
| 14.34 | 0.64 |
| 16.22 | 0.65 |
| 18.76 | 0.66 |
| 20.04 | 0.67| | 158 |
null | |Characteristic | Neuchite | Monteregie |
|---|---|---|
| Biological control | 76.37 | 86.06 |
| Deer protection | 51.18 | 66.42 |
| Rodents protection | 41.56 | 50.79 |
| Deer reduction | 30.48 | 46.57 |
| Fencing | 13.34 | 37.34 |
| Rodents vaccination | 26.0 | 32.53 |
| Acaricides | 12.28 | 28.9 |
| Landscaping | 9.84 | 16.24| | 159 |
null | |Characteristic | %OB | %LPG |
|---|---|---|
| <1 | 68.83 | 81.67 |
| 1-5 | 20.58 | 11.91 |
| 5-10 | 3.58 | 1.84 |
| 10-20 | 6.7 | 3.92| | 160 |
null | |Characteristic | Threat + Efficacy + Anger | Threat + Efficacy | Anger Only | Control |
|---|---|---|---|---|
| Pre | 42578.66 | 46971.6 | 42227.72 | 40486.98 |
| Post | 40163.15 | 38881.69 | 43035.26 | 36040.62| | 161 |
null | |Characteristic | u=0.001 | u=0.005 | u=0.01 |
|---|---|---|---|
| L=0.5 | 3.79 | 2.08 | 1.18 |
| L=0.6 | 4.85 | 2.79 | 1.69 |
| L=0.65 | 5.1 | 3.19 | 1.89| | 162 |
null | |Characteristic | CPFCAQ (Time 1) | CPFCAQ (Time 2) | CPFCAQ (Time 3) | DAQ (Time 1) | DAQ (Time 2) | DAQ (Time 3) | K10 (Time 1) | K10 (Time 2) | K10 (Time 3) |
|---|---|---|---|---|---|---|---|---|---|
| Control Group|
|(Cancer Patients) | 73.46 | 73.89 | 74.53 | 70.87 | 73.89 | 74.75 | 49.29 | 50.15 | 49.72 |
| Control Group|
|(Primary Caregivers) | 74.97 | 74.97 | 74.97 | 74.53 | 74.32 | 74.75 | 50.15 | 49.72 | 49.94 |
| Treatment Group|
|(Cancer Patients) | 73.89 | 27.07 | 19.09 | 71.3 | 28.8 | 18.22 | 50.15 | 16.07 | 14.34 |
| Treatment Group|
|(Primary Caregivers) | 74.97 | 31.82 | 19.03 | 74.97 | 33.54 | 18.22 | 50.15 | 15.04 | 13.48| | 163 |
null | |Characteristic | [unnamed data series #0] | [unnamed data series #1] | [unnamed data series #2] | [unnamed data series #3] |
|---|---|---|---|---|
| 0.0 | 8.46 | 10.41 | 13.51 | 13.34 |
| 10.0 | 11.48 | 14.01 | 14.31 | 13.95 |
| 20.0 | 14.07 | 18.05 | 15.75 | 14.62| | 164 |
null | |Characteristic | Public health aspects | Indicated disorder's characteristics | Health technology's characteristics |
|---|---|---|---|
| MEDICAL PROFESSIONALS | 22.0 | 32.0 | 46.0 |
| HEALTHTH AUTHRITIES | 22.0 | 36.0 | 42.0 |
| PATIENT REPRESENTATIVES | 24.0 | 30.0 | 46.0 |
| INDUSTRY REPRESENTATIVES | 25.0 | 32.0 | 43.0| | 165 |
null | |Characteristic | Value |
|---|---|
| 0.0 | 0.33 |
| 2.5 | 17.61 |
| 5.0 | 24.98 |
| 10.0 | 44.52 |
| 20.0 | 64.42| | 166 |
null | |Characteristic | Value |
|---|---|
| Lack of knowledge | 6.0 |
| Lack of skills | 11.0 |
| Lack of liaison with voluntary groups | 28.0 |
| Lack of political support | 33.0 |
| Lack of coherent strategy | 39.0 |
| Lack of resources | 51.0| | 167 |
null | |Characteristic | Days | STATUS |
|---|---|---|
| ssGBLUP | 85.42 | 83.34 |
| wssGBLUP2 | 97.36 | 94.77 |
| wssGBLUP3 | 91.65 | 89.06 |
| BayesB | 109.1 | 97.36| | 168 |
null | |Characteristic | Aarhus (DK) | Reykjavik (IS) | Bergen (NO) | Gothenburg (SE) | Umea (SE) | Uppsala (SE) | Tartu (EE) |
|---|---|---|---|---|---|---|---|
| City | 1.01 | 1.01 | 1.02 | 1.04 | 1.0 | 1.03 | 1.02 |
| Suburb | 1.15 | 0.87 | 1.0 | 0.84 | 0.54 | 0.99 | 0.43 |
| Town | 1.45 | 0.93 | 1.12 | 1.26 | 0.75 | 1.03 | 0.63 |
| Village | 1.07 | 1.1 | 1.09 | 0.93 | 0.55 | 1.1 | 0.56 |
| Farm-livestock | 2.42 | 0.37 | 0.7 | 0.53 | 0.56 | 0.67 | 0.44 |
| Farm+livestock | 0.48 | 0.64 | 0.91 | 1.04 | 0.58 | 0.88 | 0.35| | 169 |
null | |Characteristic | Coarse | Fine | Ultrafine |
|---|---|---|---|
| Na | 0.42 | 0.52 | 0.06 |
| Mg | 0.53 | 0.41 | 0.06 |
| Al | 0.57 | 0.36 | 0.07 |
| K | 0.17 | 0.75 | 0.08 |
| Ti | 0.52 | 0.36 | 0.12 |
| V | 0.07 | 0.79 | 0.14 |
| Cr | 0.37 | 0.42 | 0.21 |
| Mn | 0.26 | 0.68 | 0.06 |
| Fe | 0.43 | 0.46 | 0.11 |
| Ni | 0.29 | 0.6 | 0.11 |
| Cu | 0.2 | 0.68 | 0.12 |
| Zn | 0.1 | 0.8 | 0.09 |
| Cd | 0.03 | 0.9 | 0.07 |
| Pb | 0.07 | 0.85 | 0.08| | 170 |
null | |Characteristic | Value |
|---|---|
| 1.0 | 1.69 |
| 2.0 | 1.41 |
| 3.0 | 1.27 |
| 4.0 | 1.25 |
| 5.0 | 1.29| | 171 |
null | |Characteristic | Value |
|---|---|
| Water quality | 79.89 |
| Channel blockage | 40.37 |
| Disappearance of small rivers | 39.39 |
| Riparian zone destruction | 10.42 |
| Channel straightening | 57.46| | 172 |
null | |Characteristic | 2010 | 2011 | 2012 | 2013 |
|---|---|---|---|---|
| Jan | 0.95 | 0.38 | 0.74 | 1.41 |
| Feb | 0.63 | 1.4 | 1.88 | 1.61 |
| Mar | 0.22 | 0.35 | 0.79 | 0.69 |
| Apr | 0.85 | 0.49 | 0.23 | 0.99 |
| May | 1.5 | 0.68 | 0.45 | 1.52 |
| Jun | 2.41 | 2.51 | 3.16 | 4.99 |
| Jul | 6.15 | 2.27 | 2.69 | 7.59 |
| Aug | 3.81 | 7.87 | 9.3 | 4.5 |
| Sep | 5.04 | 4.72 | 4.58 | 6.08 |
| Oct | 4.6 | 5.67 | 2.13 | 3.74 |
| Nov | 1.67 | 1.95 | 2.2 | 2.34 |
| Dec | 1.63 | 2.9 | 0.57 | 1.22| | 173 |
null | |Characteristic | Value |
|---|---|
| 6 Hours Before Injury | 90.74 |
| Typical Drinking Habits | 101.54| | 174 |
null | |Characteristic | Primer Set 1 | Primer Set 2 | Primer Set 3 | Primer Set 4 |
|---|---|---|---|---|
| Acineiobacter sp. | 0.02 | 0.02 | 0.98 | 0.02 |
| Cedeca sp. | 0.02 | 0.98 | 0.01 | 0.02 |
| Citrobacter sp. | 1.96 | 2.94 | 0.01 | 1.96 |
| Cronobacter sp. | 0.02 | 0.02 | 0.98 | 0.02 |
| Enterobacter sp. | 0.98 | 1.94 | 1.96 | 0.98 |
| Klebsiella sp. | 0.98 | 0.98 | 0.98 | 0.98 |
| Kluyvera sp. | 0.98 | 0.02 | 0.02 | 0.98 |
| Leclercia sp. | 0.02 | 0.98 | 0.98 | 0.02 |
| Lelliottia sp. | 0.98 | 0.98 | 0.98 | 0.98 |
| Panloea sp. | 0.98 | 0.01 | 0.02 | 0.98 |
| Pectobacterium sp. | 0.02 | 0.98 | 1.94 | 0.02 |
| Pseudomonas sp. | 1.96 | 0.02 | 0.02 | 1.96 |
| Rabnella sp. | 0.01 | 0.98 | 0.02 | 0.02 |
| Tatumella sp. | 0.98 | 0.98 | 0.01 | 0.98| | 175 |
null | |Characteristic | Value |
|---|---|
| 0.0 | 1.23 |
| 0.1 | 1.43 |
| 0.2 | 1.59 |
| 0.5 | 2.17 |
| 1.0 | 1.99| | 176 |
null | |Characteristic | Measured | Predicted |
|---|---|---|
| Ni/Al_2O_3 | 0.12 | 0.16 |
| Ni/SiC | 0.05 | 0.06 |
| Ni/ZrO_2 | 0.03 | 0.03 |
| Ni/GPL | 0.0 | 0.0| | 177 |
null | |Characteristic | Control | Low | Medium | High |
|---|---|---|---|---|
| 0W | 103.5 | 105.34 | 111.84 | 110.07 |
| 4W | 213.5 | 221.82 | 226.81 | 233.32 |
| 8W | 265.81 | 279.86 | 277.05 | 289.23 |
| 12W | 292.14 | 308.22 | 304.32 | 314.38 |
| 16W | 311.56 | 324.81 | 325.75 | 330.49 |
| 20W | 329.74 | 342.51 | 347.17 | 346.1 |
| 24W | 339.11 | 343.79 | 353.66 | 357.91| | 178 |
null | |Characteristic | [unnamed data series #0] | [unnamed data series #1] |
|---|---|---|
| Knowledge | 0.37 | 0.63 |
| Attitude | 0.64 | 0.36 |
| Practice | 0.66 | 0.34| | 179 |
null | |Characteristic | Pain Outpatient Clinic | Mind-Body Training Programs | Rehabilitation |
|---|---|---|---|
| Weakness/Failure | 1.15 | 0.63 | 1.31 |
| Punishment | 1.27 | 0.48 | 1.29 |
| Interrupt/Loss | 2.78 | 1.26 | 2.54 |
| Enemy/Threat | 1.83 | 0.88 | 1.57 |
| Reliving Break | 0.99 | 0.65 | 1.38 |
| Call for Help/Strategy | 1.41 | 0.94 | 1.76 |
| Value | 1.48 | 0.96 | 1.55 |
| Challenge | 1.71 | 1.33 | 1.9| | 180 |
null | |Characteristic | Value |
|---|---|
| 0.35 | 0.99 |
| 30.1 | 0.98 |
| 60.2 | 0.97 |
| 89.95 | 0.92 |
| 120.39 | 0.91 |
| 149.8 | 0.9 |
| 180.25 | 0.88| | 181 |
null | |Characteristic | 24h | 48h | 72h |
|---|---|---|---|
| control | 99.02 | 98.03 | 98.2 |
| Plutronic | 86.0 | 81.0 | 79.02 |
| Plu/Chito 10% | 94.1 | 91.31 | 91.15 |
| Plu/Chito 15% | 92.13 | 90.0 | 90.16 |
| Plu/DPPC 100 | 84.0 | 79.02 | 75.9 |
| Plu/DPPC 200 | 87.0 | 82.0 | 80.0 |
| Plu/DMPC 100 | 91.15 | 90.0 | 89.0 |
| Plu/DMPC200 | 93.11 | 93.11 | 92.3 |
| F10% DMPC 100 | 93.11 | 90.16 | 88.17 |
| F10% DMPC200 | 94.1 | 91.97 | 91.15 |
| F10% DPPC 100 | 88.17 | 85.0 | 84.0 |
| F10% DPPC 200 | 86.0 | 85.0 | 82.0 |
| F15% DPPC 100 | 95.08 | 95.08 | 93.11 |
| F15% DMPC 200 | 96.07 | 94.1 | 92.95 |
| F15% DPPC 100 | 95.08 | 95.08 | 93.11 |
| F15% DPPC 200 | 96.07 | 94.26 | 94.1| | 182 |
null | |Characteristic | Value |
|---|---|
| being male | 8.62 |
| inadequate fruits | 13.94 |
| inadequate vegetables | 18.95 |
| genetic | 30.23 |
| smokeless tobacco | 30.23 |
| high blood sugar | 34.62 |
| old age | 34.62 |
| excess alcohol | 43.39 |
| high blood cholestrol | 43.39 |
| stress | 47.78 |
| overweight | 52.16 |
| lack of physical activity | 56.55 |
| smoking | 60.94 |
| high blood pressure | 65.01| | 183 |
null | |Characteristic | Value |
|---|---|
| 18-29 years | 47.38 |
| 30-39 years | 63.22 |
| 40-49 years | 63.84 |
| 50-59 years | 52.66 |
| 65+ years | 24.7| | 184 |
null | |Characteristic | Value |
|---|---|
| non treated | 195.95 |
| 10 kGy | 109.26 |
| 50 kGy | 76.44 |
| 100 kGy | 43.81 |
| 200 kGy | 36.73| | 185 |
null | |Characteristic | April | September |
|---|---|---|
| Moveable | 564.52 | 305.67 |
| Non-Moveable | 80.34 | 107.98 |
| Disposable | 191.96 | 126.65 |
| Non-disposable | 450.82 | 286.31| | 186 |
null | |Characteristic | Educational achievements | Social life | (Un) healthy behavior | Perceived life control | Emotions | Self-confidence | Employability | Family life | Physical environment | Justice and security | End of life aspects | Other | Use of medical treatment | Perceptions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| [unnamed category #0] | 31.97 | 23.04 | 22.0 | 18.02 | 16.02 | 12.11 | 8.05 | 5.09 | 5.09 | 5.09 | 4.06 | 4.06 | 3.1 | 2.14| | 187 |
null | |Characteristic | Value |
|---|---|
| 14.6 | 4.31 |
| 13.6 | 4.78 |
| 12.6 | 5.65 |
| 11.6 | 6.52 |
| 10.6 | 9.09 |
| 9.6 | 11.59 |
| 8.6 | 16.6| | 188 |
null | |Characteristic | Value |
|---|---|
| LSB | 108.28 |
| LCBS-1 | 44.67 |
| LCBS-2 | 46.26 |
| LCBS-3 | 44.21 |
| LCBA-1 | 13.49 |
| LCBA-2 | 14.85 |
| LCBA-3 | 25.09| | 189 |
null | |Characteristic | Anal sex | Oral sex |
|---|---|---|
| Self preference | 71.1 | 38.5 |
| More sexual pleasure | 65.8 | 45.9 |
| Partner Choice | 67.1 | 54.7 |
| Minimize the risk of STI | 82.9 | 80.4 |
| Maintain virginity | 85.5 | 85.8 |
| Minimize the risk of HIV | 77.6 | 86.5 |
| Minimize the risk of pregnancy | 92.1 | 95.9| | 190 |
null | |Characteristic | Television | Radio | Cinema | Posters/bill board | Shops | Nespaper | Other source |
|---|---|---|---|---|---|---|---|
| [unnamed category #0] | 630.09 | 1601.88 | 42.32 | 191.22 | 183.39 | 57.99 | 144.2| | 191 |
null | |Characteristic | Hospital in-patient | At an out-patient clinic with a specialist doctor | Consultation with your family practitioner/GP | Hospital emergency department |
|---|---|---|---|---|
| Brazil | 37.13 | 49.06 | 53.04 | 25.2 |
| China | 1.1 | 33.15 | 39.23 | 1.1 |
| Germany | 3.32 | 27.3 | 51.17 | 2.04 |
| Turkey | 14.2 | 61.23 | 46.02 | 22.16 |
| UK | 12.33 | 29.17 | 63.1 | 10.22 |
| USA | 4.14 | 27.3 | 48.36 | 4.14| | 192 |
null | |Characteristic | Occupational | Non-occupational |
|---|---|---|
| Metal | 316.32 | 247.97 |
| Traffic | 11.72 | 87.5 |
| Plastic | 11.72 | 57.78 |
| Chemical | 35.49 | 22.12 |
| Stone | 4.29 | 45.9 |
| Glass | 20.64 | 22.12 |
| Wood | 7.26 | 32.03 |
| Electric arc | 29.55 | 6.27 |
| Hot liquid | 22.12 | 8.75 |
| Explosive | 8.75 | 20.64 |
| Others | 7.26 | 80.07| | 193 |
null | |Characteristic | Average | Advanced |
|---|---|---|
| Database, design and setup | 8.45 | 2.31 |
| Programming | 9.22 | 1.54 |
| Database, use existing ore | 12.68 | 3.84 |
| Setup system, install software | 14.21 | 2.69 |
| Graphics (presentation and Powerpoint) | 16.9 | 2.31 |
| Spreadsheets (Excel) | 22.67 | 3.84 |
| Wordprocessing | 28.43 | 6.15 |
| Windows | 30.35 | 11.14 |
| File Management | 34.19 | 19.98 |
| Internet | 36.11 | 22.67 |
| Email | 40.34 | 36.11| | 194 |
null | |Characteristic | T0 | T1 | T2 | T3 |
|---|---|---|---|---|
| 1.0 | 27.9 | 32.02 | 15.01 | 21.99 |
| 2.0 | 34.7 | 31.36 | 24.68 | 24.68 |
| 3.0 | 34.52 | 32.73 | 25.27 | 27.9 |
| 4.0 | 37.39 | 38.28 | 29.33 | 32.79 |
| 5.0 | 48.31 | 51.05 | 47.23 | 49.14| | 195 |
null | |Characteristic | As-extruded Alloys | Aged Alloys |
|---|---|---|
| 0Ti | 20.15 | 76.03 |
| 0.02Ti | 5.45 | 12.33 |
| 0.3Ti | 7.51 | 2.37 |
| 0.5Ti | 5.14 | 0.0| | 196 |
null | |Characteristic | 100ng/mL | 10ug/mL |
|---|---|---|
| SEA | 2.86 | 2.76 |
| SEB | 0.14 | 0.12 |
| SEC | 0.11 | 0.09 |
| SED | 0.14 | 0.17 |
| SEE | 0.16 | 1.03| | 197 |
null | |Characteristic | 3 days | 7 days |
|---|---|---|
| TCP | 0.61 | 1.19 |
| W—D glass ceramic foam | 0.46 | 0.9| | 198 |
null | |Characteristic | Value |
|---|---|
| Baseline | 0.33 |
| Lit | 0.34 |
| Audio warning | 0.47 |
| Lit+Audio | 0.37| | 199 |